Evidence map›Paper›PMID 37214524›Full record

ArticlePEC innovation2023

Investigation of interest in and timing preference for cancer predisposition testing and expanded carrier screening among women of reproductive age.

Lingzi Zhong, Jemar R Bather, Brianne M Daly, Wendy K Kohlmann, Melody S Goodman, Erin Rothwell, Kimberly A Kaphingst

Registry-linked trialAbstract read
In one paragraph

Article in PEC innovation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07052266 (Feasibility of Obstetric and Cancer Universal Screening), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07052266 narecruitingnot on this mapstarted 2025, after this paper: background citation

Feasibility of Obstetric and Cancer Universal Screening

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2025 to 2028Enrolled550ConditionsHereditary Cancer SyndromesArmsMyRisk Hereditary Cancer Test
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingzi ZhongHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Jemar R BatherDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Brianne M DalyHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Wendy K KohlmannHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Melody S GoodmanDepartment of Biostatistics, New York University School of Global Public Health, New York City, NY, United States.
Erin RothwellDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, UT, USA.
Kimberly A KaphingstHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.

Funding

Utah Center of Excellence in ELSI Research: UCEERRM1HG009037 · NHGRI · UNIVERSITY OF UTAH · PI ROTHWELL, ERIN, TABERY, JAMES · 2016 to 2024
$8.0M
NHGRI NIH HHS RM1 HG009037
6 · The paper itself

Abstract

Objective: To examine cognitive, relational, and social predictors of interest in and timing preference for cancer predisposition testing (CPT) and expanded carrier screening (ECS) offered in routine gynecologic care for women of reproductive age. Methods: Women between 20 and 35 years old who were currently pregnant or had a prior pregnancy ( Results: Most respondents reported high interest in CPT and ECS and preferred to have them when planning for a pregnancy. Perceived importance of genetic information and negative attitude towards uncertainty predicted interest in CPT and ECS in multivariable models. Genetic knowledge predicted preference for CPT or ECS when planning for a pregnancy. Conclusion: Educational and decision support tools should be developed to enhance women's knowledge and awareness of CPT and ECS and to provide them with strategies to manage uncertainty. Innovation: We examined women's timing preference for CPT and ECS and the impact of partner support and trust with gynecologist. A context-specific attitudes toward uncertainty scale was used to investigate women's particular perceptions of uncertainty in genetic testing.

Indexed as

Cancer predisposition testingExpanded carrier screeningInterestPregnancyTiming preference

Identifiers

PMID37214524
PMCPMC10194195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.